These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25824098)
1. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1. Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V; J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098 [TBL] [Abstract][Full Text] [Related]
2. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma. Pasquali D; Circelli L; Faggiano A; Pancione M; Renzullo A; Elisei R; Romei C; Accardo G; Coppola VR; De Palma M; Ferolla P; Grimaldi F; Colao A; Colantuoni V Eur J Endocrinol; 2011 Mar; 164(3):397-404. PubMed ID: 21177330 [TBL] [Abstract][Full Text] [Related]
3. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations. Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291 [TBL] [Abstract][Full Text] [Related]
4. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308 [TBL] [Abstract][Full Text] [Related]
5. Clinical Profile and Mutations Associated with Multiple Endocrine Neoplasia-Type1 (MEN1) and Their First-Degree Relatives at Risk of Developing MEN1: A Prospective Study. Shyamasunder AH; Pai R; Ramamoorthy H; Sakhti D; Manipadam MT; Kapoor N; Paul TV; Jebasingh F; Thomas N; Abraham DT; Paul MJ; Chacko AG; Prabhu K; Rajaratnam S Horm Metab Res; 2021 Apr; 53(4):245-256. PubMed ID: 33853118 [TBL] [Abstract][Full Text] [Related]
6. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502 [TBL] [Abstract][Full Text] [Related]
7. Multiple endocrine neoplasia, the old and the new: a mini review. Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918 [TBL] [Abstract][Full Text] [Related]
8. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066 [TBL] [Abstract][Full Text] [Related]
9. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain. Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S; Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891 [TBL] [Abstract][Full Text] [Related]
11. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations. Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function. Lindberg D; Akerström G; Westin G Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155 [TBL] [Abstract][Full Text] [Related]
13. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype. Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674 [TBL] [Abstract][Full Text] [Related]
14. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699 [TBL] [Abstract][Full Text] [Related]
15. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs. Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578 [TBL] [Abstract][Full Text] [Related]
16. Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review. Chevalier B; Coppin L; Romanet P; Cuny T; Maïza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF J Clin Endocrinol Metab; 2024 Jun; 109(7):e1482-e1493. PubMed ID: 38288531 [TBL] [Abstract][Full Text] [Related]
17. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1. Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours. Lindberg D; Akerström G; Westin G Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708 [TBL] [Abstract][Full Text] [Related]